These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 16821598)
1. Topotecan in the treatment of brain metastases. A phase II study of GOIM (Gruppo Oncologico dell'Italia Meridionale). Lorusso V; Galetta D; Giotta F; Rinaldi A; Romito S; Brunetti C; Silvestris N; Colucci G Anticancer Res; 2006; 26(3B):2259-63. PubMed ID: 16821598 [TBL] [Abstract][Full Text] [Related]
2. [Clinical study of topotecan in the treatment of small cell lung cancer and recurrent ovarian cancer]. Feng F; He X; Shi Y Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):155-8. PubMed ID: 11783024 [TBL] [Abstract][Full Text] [Related]
3. Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma. Tas F; Derin D; Guney N; Camlica H; Aydiner A; Topuz E Lung Cancer; 2007 Jul; 57(1):79-83. PubMed ID: 17383768 [TBL] [Abstract][Full Text] [Related]
4. Hematologic safety and tolerability of topotecan in recurrent ovarian cancer and small cell lung cancer: an integrated analysis. Armstrong DK; Spriggs D; Levin J; Poulin R; Lane S Oncologist; 2005 Oct; 10(9):686-94. PubMed ID: 16249347 [TBL] [Abstract][Full Text] [Related]
5. Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402. Inoue A; Sugawara S; Yamazaki K; Maemondo M; Suzuki T; Gomi K; Takanashi S; Inoue C; Inage M; Yokouchi H; Watanabe H; Tsukamoto T; Saijo Y; Ishimoto O; Hommura F; Nukiwa T J Clin Oncol; 2008 Nov; 26(33):5401-6. PubMed ID: 18854562 [TBL] [Abstract][Full Text] [Related]
6. Topotecan in the treatment of recurrent small cell lung cancer: an update. Ardizzoni A Oncologist; 2004; 9 Suppl 6():4-13. PubMed ID: 15616145 [TBL] [Abstract][Full Text] [Related]
7. Long time therapy with topotecan in patients with recurrence of ovarian carcinoma. Möbus V; Pfaff PN; Volm T; Kreienberg R; Kaubitzsch S Anticancer Res; 2001; 21(5):3551-6. PubMed ID: 11848522 [TBL] [Abstract][Full Text] [Related]
8. Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer. Eckardt JR; von Pawel J; Pujol JL; Papai Z; Quoix E; Ardizzoni A; Poulin R; Preston AJ; Dane G; Ross G J Clin Oncol; 2007 May; 25(15):2086-92. PubMed ID: 17513814 [TBL] [Abstract][Full Text] [Related]
9. Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trial. Sorensen M; Lassen U; Palshof T; Jensen BB; Johansen J; Jensen PB; Langer SW Lung Cancer; 2008 May; 60(2):252-8. PubMed ID: 18036701 [TBL] [Abstract][Full Text] [Related]
10. [Effect of topotecan as a second line treatment in small cell lung cancer patients. Preliminary report]. Biernacka B; Krawczyk P; Buczkowski J; Siwiec A; Perzyło K; Milanowski J Pneumonol Alergol Pol; 2010; 78(3):192-202. PubMed ID: 20461687 [TBL] [Abstract][Full Text] [Related]
11. Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancer. Miller AA; Al Omari A; Murry DJ; Case D Lung Cancer; 2006 Dec; 54(3):379-85. PubMed ID: 17049403 [TBL] [Abstract][Full Text] [Related]
12. Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: a multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603). Galetta D; Gebbia V; Silvestris N; Ferraù F; Carrozza F; Cigolari S; Russo P; Calista F; Adamo V; Colucci G Lung Cancer; 2011 Apr; 72(1):59-63. PubMed ID: 20728237 [TBL] [Abstract][Full Text] [Related]
13. Emerging role of weekly topotecan in recurrent small cell lung cancer. Eckardt JR Oncologist; 2004; 9 Suppl 6():25-32. PubMed ID: 15616147 [TBL] [Abstract][Full Text] [Related]
14. [Systemic chemotherapy for brain metastasis from small cell lung cancer]. Tanaka H; Takifuji N; Masuda N; Takada M; Kudo S; Nakagawa K; Matsui K; Ito K; Kusunoki Y; Fukuoka M Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Apr; 31(4):492-7. PubMed ID: 8390590 [TBL] [Abstract][Full Text] [Related]
15. Topotecan in the treatment of elderly patients with relapsed small-cell lung cancer. Garst J; Buller R; Lane S; Crawford J Clin Lung Cancer; 2005 Nov; 7(3):190-6. PubMed ID: 16354314 [TBL] [Abstract][Full Text] [Related]
16. Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM). Gebbia V; Caruso M; Borsellino N; Ajello R; Tirrito ML; Chiarenza M; Valenza R; Verderame F; Varvara F; Marrazzo A; Bajardi E; Ferrao F; Bordonaro R; Tralongo P Anticancer Res; 2006; 26(4B):3143-50. PubMed ID: 16886648 [TBL] [Abstract][Full Text] [Related]
17. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis. Fortin D; Gendron C; Boudrias M; Garant MP Cancer; 2007 Feb; 109(4):751-60. PubMed ID: 17211866 [TBL] [Abstract][Full Text] [Related]
18. A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer. Shah C; Ready N; Perry M; Kirshner J; Gajra A; Neuman N; Garziano S Lung Cancer; 2007 Jul; 57(1):84-8. PubMed ID: 17399850 [TBL] [Abstract][Full Text] [Related]
19. A phase I/II trial of topotecan and radiation therapy for brain metastases in patients with solid tumors. Hedde JP; Neuhaus T; Schüller H; Metzler U; Schmidt-Wolf IG; Kleinschmidt R; Losem C; Lange O; Grohe C; Stier S; Ko YD Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):839-44. PubMed ID: 17379446 [TBL] [Abstract][Full Text] [Related]